These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30153332)

  • 1. Immune hemolysis secondary to injection of contrast medium.
    Maurin C; Vassal O; Darien M; Raba M; Allaouchiche B; Piriou V
    Transfusion; 2018 Sep; 58(9):2113-2114. PubMed ID: 30153332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular immune hemolysis caused by the contrast medium iomeprol.
    Mayer B; Leo A; Herziger A; Houben P; Schemmer P; Salama A
    Transfusion; 2013 Oct; 53(10):2141-4. PubMed ID: 23347254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.
    Gniadek TJ; Arndt PA; Leger RM; Zydowicz D; Cheng EY; Zantek ND
    Transfusion; 2018 Jan; 58(1):181-188. PubMed ID: 28990203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of iomeprol by hemodialysis.
    Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Sakaguchi K
    Eur J Radiol; 1996 Nov; 23(3):197-200. PubMed ID: 9003924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
    Linnik YA; Tsui EW; Martin IW; Szczepiorkowski ZM; Denomme GA; Gottschall JL; Hill JM; Dunbar NM
    Transfusion; 2017 Dec; 57(12):2937-2941. PubMed ID: 28905389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the adverse effects of iomeprol.
    Schmiedel E
    Eur J Radiol; 1994 May; 18 Suppl 1():S104-8. PubMed ID: 8020511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.
    Watanabe H; Sueki H; Nakada T; Akiyama M; Iijima M
    Dermatology; 1999; 198(3):291-4. PubMed ID: 10393456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
    Lexmaulova L; Zatloukal J; Proks P; Dvorak M; Srnec R; Rauser P; Kecova H; Necas A
    J Vet Emerg Crit Care (San Antonio); 2009 Dec; 19(6):611-6. PubMed ID: 20017767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
    Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lethal reaction after contrast medium administration].
    Risgaard O; Søe CK; Zejden A
    Ugeskr Laeger; 2008 Apr; 170(17):1474. PubMed ID: 18462629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of radiographic contrast media (Iomeprol 350 versus Iopentol 350) on cutaneous microcirculation: single-center prospective randomized double-blind phase iv study in parallel-group design.
    Jung F; Spitzer S; Mrowietz C; Sternitzky R; Bach R
    J Invasive Cardiol; 1999 Jan; 11(1):2-8. PubMed ID: 10745429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
    Schmiedel E
    Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate reactions to iodinated contrast media.
    Morales-Cabeza C; Roa-Medellín D; Torrado I; De Barrio M; Fernández-Álvarez C; Montes-Aceñero JF; De La Riva I; Prieto-García A
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):553-557. PubMed ID: 29017901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-induced immune hemolytic anemia caused by cefmetazole].
    Shioji N; Mizutani M; Okayama M; Katayama H; Ooya E; Sekine T; Masuya M
    Rinsho Ketsueki; 2018; 59(7):884-888. PubMed ID: 30078798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
    Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
    Perm J; 2020; 24():. PubMed ID: 31905339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
    Jabr FI; Shamseddine A; Taher A
    Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report.
    Fukuda M; Nabeta M; Oya S; Takasu O
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):52-56. PubMed ID: 34672255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.